BLRX
BioLineRX
BLRX
BLRX
28 hedge funds and large institutions have $40.9M invested in BioLineRX in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
6% less capital invested
Capital invested by funds: $43.4M → $40.9M (-$2.45M)
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$180K | |
| 2 | +$152K | |
| 3 | +$95K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$46.1K |
| 5 |
JPMorgan Chase & Co
New York
|
+$31K |
Top Sellers
| 1 | -$1.68M | |
| 2 | -$51K | |
| 3 | -$46.9K | |
| 4 |
Bank of New York Mellon
New York
|
-$20K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$18K |